@dr-jayne-ellis.bsky.social
AHD clinical researcher, Infectious Diseases Institute, Kampala, Uganda
Wellcome Global Health Research Clinical PhD Fellow, LSHTM
Infectious Disease/Micro trainee, UCLH
Wellcome Global Health Research Clinical PhD Fellow, LSHTM
Infectious Disease/Micro trainee, UCLH
Reposted
⚡️New preprint (not peer-reviewed)⚡️
In the SaDAPT trial with people with #HIV and #tuberculosis symptoms in 🇲🇼🇱🇸, we investigated if antiretroviral therapy should be initiated immediately, or delayed until TB results available. ssrn.com/abstract=523...
Outcomes (incl. IRIS) similar across both arms.
In the SaDAPT trial with people with #HIV and #tuberculosis symptoms in 🇲🇼🇱🇸, we investigated if antiretroviral therapy should be initiated immediately, or delayed until TB results available. ssrn.com/abstract=523...
Outcomes (incl. IRIS) similar across both arms.
May 1, 2025 at 7:10 AM
⚡️New preprint (not peer-reviewed)⚡️
In the SaDAPT trial with people with #HIV and #tuberculosis symptoms in 🇲🇼🇱🇸, we investigated if antiretroviral therapy should be initiated immediately, or delayed until TB results available. ssrn.com/abstract=523...
Outcomes (incl. IRIS) similar across both arms.
In the SaDAPT trial with people with #HIV and #tuberculosis symptoms in 🇲🇼🇱🇸, we investigated if antiretroviral therapy should be initiated immediately, or delayed until TB results available. ssrn.com/abstract=523...
Outcomes (incl. IRIS) similar across both arms.
Data from the intensive IMPROVE PK study amongst Ugandan adults with advanced HIV disease receiving once daily DTG with 1HP presented at IAS this week.
July 16, 2025 at 1:15 PM
Data from the intensive IMPROVE PK study amongst Ugandan adults with advanced HIV disease receiving once daily DTG with 1HP presented at IAS this week.
Reposted
Can't believe the EMPIRICAL study showing reduced MORTALITY in kids with pneumonia given valganciclovir didn't get an oral! Come on #IAS2025. This is a VERY important finding.
July 16, 2025 at 8:21 AM
Can't believe the EMPIRICAL study showing reduced MORTALITY in kids with pneumonia given valganciclovir didn't get an oral! Come on #IAS2025. This is a VERY important finding.
Reposted
Jayne Ellis presenting data from our cohort with CD4 <100 undergoing CrAg screening in SA at #IAS2025 (poster 2803)
59% (86/146) had CMV viraemia - strongly & independently associated with ⬆️mortality, more than quadrupling odds of death at 6-months (adjusted OR 4.02, 95%CI 1.27-12.7)
59% (86/146) had CMV viraemia - strongly & independently associated with ⬆️mortality, more than quadrupling odds of death at 6-months (adjusted OR 4.02, 95%CI 1.27-12.7)
July 14, 2025 at 8:36 AM
Jayne Ellis presenting data from our cohort with CD4 <100 undergoing CrAg screening in SA at #IAS2025 (poster 2803)
59% (86/146) had CMV viraemia - strongly & independently associated with ⬆️mortality, more than quadrupling odds of death at 6-months (adjusted OR 4.02, 95%CI 1.27-12.7)
59% (86/146) had CMV viraemia - strongly & independently associated with ⬆️mortality, more than quadrupling odds of death at 6-months (adjusted OR 4.02, 95%CI 1.27-12.7)